Abstract
The height and age at presentation of 458 children beginning treatment with growth hormone between January 1980 and June 1984 were retrospectively analysed. Three hundred and nine children with isolated growth hormone deficiency had a mean (SD) age of 10 (4.1) years on beginning treatment and a mean (SD) height standard deviation score (SDS) of -3.73 (0.93). One hundred and nine patients with hypothalamopituitary tumours began treatment with growth hormone on average 3.3 years after diagnosis of the tumour and at a mean (SD) height SDS of -2.42 (1.49). In both of these categories the height SDS showed a considerable improvement compared with previous reports. Forty two patients with growth hormone deficiency secondary to cranial irradiation started treatment with growth hormone on average 6.1 years after treatment for their tumours and had a height SDS of -2.45 (1.02) compared with that of -2.45 (0.98) seen in nine similar patients from the United Kingdom starting treatment with growth hormone between 1975 and 1978. Although closer surveillance of short children in the community is leading to earlier diagnosis of growth hormone deficiency, this could possibly be diagnosed earlier if routine screening of height was to be carried out at school entry. In addition, patients who have received cranial irradiation should be regularly measured and investigated when their height velocity becomes subnormal.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burns E. C., Tanner J. M., Preece M. A., Cameron N. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur J Pediatr. 1981 Oct;137(2):155–164. doi: 10.1007/BF00441309. [DOI] [PubMed] [Google Scholar]
- Green A. A., MacFarlane J. A. Method for the earlier recognition of abnormal stature. Arch Dis Child. 1983 Jul;58(7):535–537. doi: 10.1136/adc.58.7.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Griffin N. K., Wadsworth J. Effect of treatment of malignant disease on growth in children. Arch Dis Child. 1980 Aug;55(8):600–603. doi: 10.1136/adc.55.8.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Joss E., Zuppinger K., Schwarz H. P., Roten H. Final height of patients with pituitary growth failure and changes in growth variables after long term hormonal therapy. Pediatr Res. 1983 Aug;17(8):676–679. doi: 10.1203/00006450-198308000-00015. [DOI] [PubMed] [Google Scholar]
- Lenko H. L., Leisti S., Perheentupa J. The efficacy of growth hormone in different types of growth failure. An analysis of 101 cases. Eur J Pediatr. 1982 May;138(3):241–249. doi: 10.1007/BF00441210. [DOI] [PubMed] [Google Scholar]
- Shalet S. M., Beardwell C. G., Morris-Jones P. H., Pearson D. Pituitary function after treatment of intracranial tumours in children. Lancet. 1975 Jul 19;2(7925):104–107. doi: 10.1016/s0140-6736(75)90006-9. [DOI] [PubMed] [Google Scholar]
- Tanner J. M., Whitehouse R. H., Hughes P. C., Vince F. P. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints. Arch Dis Child. 1971 Dec;46(250):745–782. doi: 10.1136/adc.46.250.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tanner J. M., Whitehouse R. H., Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child. 1966 Dec;41(220):613–635. doi: 10.1136/adc.41.220.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zachmann M., Fernandez F., Tassinari D., Thakker R., Prader A. Anthropometric measurements in patients with growth hormone deficiency before treatment with human growth hormone. Eur J Pediatr. 1980 May;133(3):277–282. doi: 10.1007/BF00496089. [DOI] [PubMed] [Google Scholar]